SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : STOCKS WITH ATTITUDE TEAM - FA/TA AND EVERYTHING ELSE -- Ignore unavailable to you. Want to Upgrade?


To: ivan solotaroff who wrote (838)12/26/1997 1:09:00 PM
From: lostmymoney  Respond to of 2377
 
All, could you check out GW (grey wolf). Had .08 cents earnings this past year and is expecting .29 next year. Good sector also. Good price now.

mike



To: ivan solotaroff who wrote (838)12/26/1997 3:57:00 PM
From: Sergio H  Read Replies (1) | Respond to of 2377
 
Ivan thanks for the update on GOTK and gud yontef to you.

Sergio



To: ivan solotaroff who wrote (838)1/1/1998 12:05:00 PM
From: Sergio H  Read Replies (2) | Respond to of 2377
 
Ivan, DITI looks interesting. The company, DIATIDE is waiting for fast track decision by the FDA for Acu Test, intended for use in detecting blood clots. This would be the company's first product. Decision is expected prior to March.

The company has over $2/share in cash. There are 10.5 million shares but the float is only 3.6 millon. Two strong buys from analysts
covering; Dillon Read and Oppenheimer.

Lots of institutional and insider buying (and ownership). One insider was selling in Sept. A VP sold 5k at 7 1/2 but several institutions were buying including Equitable Co., buyer of 326k. Institutions owning shares include Merrill Lynch (8%) and Chase Manhattan (6%)

Nycomed Imaging owns 14% of the company and they are DITI's principal marketing partner. Nycomed recently paid DITI a milestone fee.

Sergio